Large-scale testing (Phase 3)Active Not RecruitingNCT02842086
What this trial is testing
Study to Evaluate the Safety and Efficacy of Emtricitabine and Tenofovir Alafenamide (F/TAF) Fixed-Dose Combination Once Daily for Pre-Exposure Prophylaxis in Men and Transgender Women Who Have Sex With Men and Are At Risk of HIV-1 Infection
Who this might be right for
Pre-Exposure Prophylaxis of HIV-1 Infection
Gilead Sciences 5,399